Denali Capital Acquisition Corp.
Status: Live Deal
U=S+W W=S@11.50
IPO Proceeds, $M $82.50M
IPO Date Apr 7, 2022
CEO Lei Huang
Left Lead Tiger Brokers
IPO Cash in Trust 102.0%
SPAC Tenor 12 + 3 + 3 + 9 + 9 + 8
IPO Sector General
IPO Geography Global
Target Company Semnur Pharmaceuticals
Deal Announced Sep 3, 2024
Deal Size, $M TBD
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote TBD
Amendment Vote Apr 11, 2025
DNQAF DNQUF DNQWF

Sign up for Free Trial

No credit card required

Sign in to view structure, cap table, and calendar of events.